Literature DB >> 8625743

Amount and composition of bone minerals in chronic liver disease.

J A Kalef-Ezra1, M H Merkouropoulos, A Challa, J Hatzikonstantinou, A H Karantanas, E V Tsianos.   

Abstract

Alterations in bone mineral are a common complication of chronic liver disease. The aim of the current study was to assess bone mineral status in patients with chronic liver disease not treated with corticosteroids and to investigate any possible correlation with the histological stage of liver disease. Bone mineral status in 27 patient with chronic active hepatitis, and 17 with active cirrhosis was compared to that of matched controls. Partial body neutron activation analysis was applied for measuring hand bone phosphorus, single-photon absorptiometry for measuring forearm bone mineral content, and dual-energy x-ray absorptiometry for measuring spinal bone mineral density. These noninvasive measurements were supplemented with data obtained by high resolution radiography and biochemistry. Decreased metacarpal cortical thickness was found in five patients, all in the cirrhotic group. In addition, both mean intact parathyroid hormone and 25-hydroxyvitamin D levels were reduced in this group of patients. The mean values of the quantities assessed by the in vivo techniques in patients in the early stages of the hepatic disease did not differ statistically from those of matched normal controls. On the contrary, these quantities were reduced by 9% in the patients at the late stages relative to controls. In conclusion, only the late stages of liver disease are associated with an increased risk of fractures.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8625743     DOI: 10.1007/bf02091545

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  24 in total

1.  Malabsorption and bone disease in prolonged obstructive jaundice.

Authors:  M ATKINSON; B E NORDIN; S SHERLOCK
Journal:  Q J Med       Date:  1956-07

2.  Osteoporosis and skeletal fractures in chronic liver disease.

Authors:  T Diamond; D Stiel; M Lunzer; M Wilkinson; J Roche; S Posen
Journal:  Gut       Date:  1990-01       Impact factor: 23.059

3.  Bone mass in women with primary biliary cirrhosis: the relation with histological stage and use of glucocorticoids.

Authors:  F N Van Berkum; R Beukers; J C Birkenhäger; P P Kooij; S W Schalm; H A Pols
Journal:  Gastroenterology       Date:  1990-10       Impact factor: 22.682

4.  Clinical, biochemical, and histological studies of osteomalacia, osteoporosis, and parathyroid function in chronic liver disease.

Authors:  R G Long; E Meinhard; R K Skinner; Z Varghese; M R Wills; S Sherlock
Journal:  Gut       Date:  1978-02       Impact factor: 23.059

5.  Bone mineral status after renal transplantation. Assessment by noninvasive techniques.

Authors:  J A Kalef-Ezra; A H Karantanas; I Hatzikonstantinou; G Sferopoulos; D K Glaros; K C Siamopoulos
Journal:  Invest Radiol       Date:  1994-02       Impact factor: 6.016

6.  Effect of 25-hydroxyvitamin D3 on vitamin D metabolites in primary biliary cirrhosis.

Authors:  M M Kaplan; M J Goldberg; D S Matloff; R M Neer; D B Goodman
Journal:  Gastroenterology       Date:  1981-10       Impact factor: 22.682

7.  Osteomalacia, vitamin D deficiency and cholestasis in chronic liver disease.

Authors:  J B Dibble; P Sheridan; R Hampshire; G J Hardy; M S Losowsky
Journal:  Q J Med       Date:  1982

8.  Radiographic morphometry and osteopenia in spinal osteoporosis.

Authors:  J F Aloia; A Vaswani; H Atkins; I Zanzi; K Ellis; S H Cohn
Journal:  J Nucl Med       Date:  1977-05       Impact factor: 10.057

9.  Hyperparathyroidism and low serum osteocalcin despite vitamin D replacement in primary biliary cirrhosis.

Authors:  V Fonseca; O Epstein; D S Gill; R K Menon; M Thomas; N McIntyre; P Dandona
Journal:  J Clin Endocrinol Metab       Date:  1987-05       Impact factor: 5.958

10.  Evidence for secondary hyperparathyroidism in the osteomalacia associated with chronic liver disease.

Authors:  J B Dibble; P Sheridan; R Hampshire; G J Hardy; M S Losowsky
Journal:  Clin Endocrinol (Oxf)       Date:  1981-10       Impact factor: 3.478

View more
  3 in total

1.  Bone disorders in experimentally induced liver disease in growing rats.

Authors:  Viktória Ferencz; Csaba Horváth; Béla Kári; János Gaál; Szilvia Mészáros; Zsuzsanna Wolf; Dalma Hegedus; Andrea Horváth; Anikó Folhoffer; Ferenc Szalay
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

2.  Elevated carboxy terminal cross linked telopeptide of type I collagen in alcoholic cirrhosis: relation to liver and kidney function and bone metabolism.

Authors:  S Møller; M Hansen; J Hillingso; J E Jensen; J H Henriksen
Journal:  Gut       Date:  1999-03       Impact factor: 23.059

3.  Effects of cirrhosis on bone mineral density and bone metabolism.

Authors:  Mehmet Turkeli; Hakan Dursun; Fatih Albayrak; Nihat Okçu; M Hamidullah Uyanik; Abdullah Uyanik; Rahşan Yıldırım; Mustafa Keleş; Omer Yılmaz
Journal:  Eurasian J Med       Date:  2008-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.